HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Sudden death occurring after anti-Hu associated paraneoplastic cerebellar degeneration and dysautonomia revealing a small cell lung carcinoma].

AbstractINTRODUCTION:
Paraneoplastic syndromes are a rare cancer complication with a frequent subacute evolution.
OBSERVATION:
A 62-year-old man was admitted presenting with a cerebellar syndrome and orthostatic hypotension with dysautonomia. Anti-Hu antibody research was positive. A subcarinal adenopathy biopsy found out a small cell lung carcinoma. Despite a treatment with immunoglobulin and chemotherapy, the patient died suddenly, after a raise of dysautonomia symptoms.
CONCLUSION:
Sudden death observations represent exceptional complications of paraneoplastic syndrome. They might be secondary to arrhythmias, ictal asystol or laryngospasm. Systematic research of paroxystic heart arrhythmias with holter-ECG in paraneoplastic syndrome may prevent sudden deaths.
AuthorsA Mirouse, D Gobert, J-M Chamouard, L Iordache, A Mekinian, O Fain
JournalLa Revue de medecine interne (Rev Med Interne) Vol. 35 Issue 11 Pg. 757-9 (Nov 2014) ISSN: 1768-3122 [Electronic] France
Vernacular TitleMort subite au cours d'une dégénérescence cérébelleuse subaiguë paranéoplasique avec dysautonomie associée aux anticorps anti-Hu révélant un cancer bronchique à petites cellules.
PMID24411475 (Publication Type: Case Reports, English Abstract, Journal Article)
CopyrightCopyright © 2014 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.
Chemical References
  • Antibodies
  • ELAV Proteins
Topics
  • Antibodies (blood)
  • Death, Sudden (etiology)
  • ELAV Proteins (immunology)
  • Humans
  • Lung Neoplasms (diagnosis)
  • Male
  • Middle Aged
  • Paraneoplastic Cerebellar Degeneration (etiology)
  • Paraneoplastic Syndromes, Nervous System (etiology)
  • Shy-Drager Syndrome (etiology)
  • Small Cell Lung Carcinoma (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: